Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria
VIM-type-producing Gram-negative bacteria (GNB) infections are difficult to treat. This is a retrospective single-center study of 34 patients who received cefiderocol for the treatment of VIM-type-producing GNB infections, including 25 <i>Pseudomonas</i> spp., 7 <i>Enterobacterales</i>, and 5 <i>Ach...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2024-09-01
|
| シリーズ: | Antibiotics |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2079-6382/13/9/874 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
